Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.004 Å; R factor = 0.055; wR factor = 0.135; data-to-parameter ratio = 13.9.
In the title 1:1 cocrystal, C 10 H 7 NO 4 ÁC 14 H 13 N 3 O 2 , molecules are linked by intermolecular C-HÁ Á ÁO, N-HÁ Á ÁO and O-HÁ Á ÁN hydrogen bonds, forming a three-dimensional network. In addition, -stacking interactions [with centroid-centroid distances of 3.5723 (19) and 3.6158 (18) Å ] are observed.
Related literature
For the use of co-crystals in drug design and delivery, see: Vishweshwar et al. (2009) ; Peterson et al. (2006) ; McNamara et al. (2006) . For anti-tuberculosis drugs containing the isoniazid core structure, see: Bijev (2006) ; Imramovský et al. (2007) ; Maccari et al. (2005) ; Schultheiss & Newman (2009) ; Shindikar & Viswanathan (2005) ; Sinha et al. (2005) ; Sriram et al. (2006) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). The use of co-crystals in drug design and delivery and as functional materials with potential applications as pharmaceuticals has recently attracted considerable interest (Vishweshwar et al., 2009; Peterson et al., 2006; McNamara et al., 2006) . Moreover, co-crystallization in particular is a reliable method for the modification of drug physical and technical properties such as solubility, dissolution rate, stability, hygroscopisity and compressibility without alternating the pharmacological behaviour of their ingredients (Schultheiss & Newman, 2009 ). Compounds incorporating the isoniazid (INH) core structure have shown high inhibitory activity in vitro (Bijev, 2006; Imramovský et al., 2007) tuberculosis (Maccari et al., 2005; Shindikar & Viswanathan, 2005; Sinha et al., 2005; Sriram et al., 2006) . In this context and on continuation of our interest in the synthesis of potentially biologically active molecules based on the core structure of isoniazid we decided to investigate the reaction of isoniazid-related hydrazones with phthalimido-acetic acid.
The reaction showed the unexpected co-crystallized product (I) with its ingridients in a 1:1 ratio. In this study we report a new co-crystallization method for the anti-tubercular drug
N′-[(E)-(4-methoxyphenyl)methylidene]pyridine-4-
carbohydrazide with (1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid and the crystal structure of their cocrystal compound. 
Computing details
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT (Bruker, 2009);  program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 1997) ; software used to prepare material for publication: WinGX (Farrugia, 1999) and PLATON (Spek, 2009 ).
Figure 1
The molecular structure of (I) with the atom numbering scheme. Displacement ellipsoids for non-H atoms are drawn at the 30% probability level.
Figure 2
The molecular packing and the hydrogen bonding viewed along the c axis. Hydrogen atoms not involved in hydrogen bonding have been omitted for clarity. ) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (

